Paul Sorgen, Ph.D., takes over INBRE program

Paul Sorgen, Ph.D., is a professor in the department of biochemistry and molecular biology

Paul Sorgen, Ph.D., is the new program director/principal investigator of the Nebraska Institutional Development Award Program (IDeA) Networks of Biomedical Research Excellence (INBRE) program replacing Jim Turpen, Ph.D., who retired from UNMC last year.

Established in 2001, the Nebraska INBRE program was created to expose students to serious biomedical research and build a statewide biomedical research infrastructure between undergraduate and graduate institutions.

“I am committed to continuing the high standards and goals of the program,” Dr. Sorgen said.

Those goals are to:

  • Strengthen the biomedical research capacity in Nebraska;
  • Build on established scientific focus areas in Nebraska including, infectious disease, cell signaling and cancer biology;
  • Provide access to research resources to increase the number of competitive investigators in Nebraska;
  • Provide hands-on laboratory experiences and research opportunities for Nebraska undergraduate students;
  • Serve as a pipeline for undergraduate students to continue in health research careers; and
  • Enhance science and technology knowledge in Nebraska’s workforce.

Dr. Sorgen received his bachelor’s degree in zoology in 1993 and doctoral degree in 1999 from the University of Florida. Upon graduation, he became a research associate in the department of biochemistry at the Albert Einstein College of Medicine in New York and was supported by a National Institutes of Health postdoctoral fellowship.

In 2003, he joined the department of biochemistry and molecular biology at UNMC where he developed and maintained a nationally funded research program through awards from the National Institutes of Health, the American Heart Association and the state of Nebraska.

“My lab is committed to advancing the understanding of the fundamental mechanisms of gap junction regulation, with particular interest and expertise in protein-protein interactions mediated by the carboxyl terminal domain of connexins,” Dr. Sorgen said.

He also is interested in mechanisms underlying the initiation and persistence of lethal cardiac rhythms.

“Changes in connexin distribution, density, and properties are characteristic of arrhythmic heart disease. Therefore, knowing what causes alteration of gap junction properties in heart disease is essential for defining the pathological substrate and devising effective therapies,” Dr. Sorgen said.

Together with his wife, Pamela, the Sorgens have two children, Chandler, 14, and Carter, 12. Along with gardening, traveling, and spending time with family and friends, Dr. Sorgen said he enjoys working out at the gym and officiating high school basketball games.

Dr. Sorgen said he had the privilege this past year of working the girl’s state basketball tournament in Lincoln.

1 comment

  1. Ming-Fong Lin, Ph.D. says:

    Congratulation on Outstanding Accomplishments!

Comments are closed.